Shanghai Composite Index Rises 12.81% This Week to 3087.53 — Data Talk
The Shanghai Composite Index is up 350.71 points or 12.81% this week to 3087.53
--Largest one-week point gain since the week ending June 5, 2015
--Largest one-week percentage gain since the week ending Nov. 14, 2008
--Up for two consecutive weeks
--Up 383.44 points or 14.18% over the last two weeks
--Largest two-week point gain since the week ending July 10, 2020
--Largest two-week percentage gain since the week ending Dec. 5, 2014
--Today it is up 86.58 points or 2.88%
--Up for eight consecutive trading days
--Up 383.44 points or 14.18% over the last eight trading days
--Largest eight-day point gain since Monday, July 13, 2020
--Largest eight-day percentage gain since Thursday, July 9, 2020
--Longest winning streak since Friday, Feb. 23, 2024, when the market rose for eight straight trading days
--Off 49.32% from its record close of 6092.06 hit Tuesday, Oct. 16, 2007
--Highest closing value since Tuesday, June 4, 2024
--Off 2.64% from its 52-week high of 3171.15 hit Monday, May 20, 2024
--Up 14.26% from its 52-week low of 2702.19 hit Monday, Feb. 5, 2024
--Down 0.74% from 52 weeks ago
--Off 2.64% from its 2024 closing high of 3171.15 hit Monday, May 20, 2024
--Up 14.26% from its 2024 closing low of 2702.19 hit Monday, Feb. 5, 2024
--Month-to-date it is up 8.63%
--Year-to-date it is up 112.59 points or 3.78%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 27, 2024 07:06 ET (11:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks